Avandia: How do you hold a moon beam in your hand?
This article was originally published in RPM Report
Executive Summary
FDA faces a tough decision on Avandia. Should it stay or should it go? There is bigger underlying issue: should the standard be different for pulling a drug than it is for approving the drug in the first place? It may be counterintuitive, but a different standard makes sense.